Does stage of illness influence recovery-focused outcomes after psychological treatment in bipolar disorder? A systematic review protocol.
Bipolar disorder
Clinical staging
Functioning
Moderator
Psychosocial interventions
Psychotherapy
Quality of life
Recovery
Stage of illness
Treatment
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
25 05 2019
25 05 2019
Historique:
received:
07
08
2018
accepted:
12
05
2019
entrez:
27
5
2019
pubmed:
28
5
2019
medline:
20
8
2020
Statut:
epublish
Résumé
There is great interest in the possibility that 'stage of illness' moderates treatment outcomes in bipolar disorder (BD). Much remains unknown about the construct of stage of illness, but there is evidence that effectiveness of psychosocial interventions may depend on factors that are plausible proxy measures of stage of illness (e.g., number of episodes). To date, reviews of this data have focused solely on clinical outcomes (particularly symptoms and relapse rates), but a range of recovery-focused outcomes (including functioning, cognitive functioning, and quality of life) have been measured in individuals with established BD. The aim of the proposed systematic review is to synthesise existing evidence for plausible proxy measures of stage of illness as moderators of recovery-focused and functional outcomes in psychosocial treatment studies of BD. The proposed review will follow PRISMA guidelines; Scopus, PsychINFO, PubMed and Web of Science will be searched for empirical studies of psychosocial interventions used for established (clinical stages 2-4) BD; and findings will be summarised in a narrative synthesis of clinical stage of illness (operationalised in proxy measures identified in existing staging models) as a moderator of recovery-focused and functional outcomes of psychosocial interventions for established bipolar disorder. This review will contribute to the literature by expanding upon previous reviews and potentially inform the psychosocial treatment of established BD. Implications include assisting clinicians, consumers and researchers to identify and select interventions most appropriate to recovery-focused goals based on individuals' clinical status. PROSPERO CRD42016037868.
Sections du résumé
BACKGROUND
There is great interest in the possibility that 'stage of illness' moderates treatment outcomes in bipolar disorder (BD). Much remains unknown about the construct of stage of illness, but there is evidence that effectiveness of psychosocial interventions may depend on factors that are plausible proxy measures of stage of illness (e.g., number of episodes). To date, reviews of this data have focused solely on clinical outcomes (particularly symptoms and relapse rates), but a range of recovery-focused outcomes (including functioning, cognitive functioning, and quality of life) have been measured in individuals with established BD. The aim of the proposed systematic review is to synthesise existing evidence for plausible proxy measures of stage of illness as moderators of recovery-focused and functional outcomes in psychosocial treatment studies of BD.
METHODS
The proposed review will follow PRISMA guidelines; Scopus, PsychINFO, PubMed and Web of Science will be searched for empirical studies of psychosocial interventions used for established (clinical stages 2-4) BD; and findings will be summarised in a narrative synthesis of clinical stage of illness (operationalised in proxy measures identified in existing staging models) as a moderator of recovery-focused and functional outcomes of psychosocial interventions for established bipolar disorder.
DISCUSSION
This review will contribute to the literature by expanding upon previous reviews and potentially inform the psychosocial treatment of established BD. Implications include assisting clinicians, consumers and researchers to identify and select interventions most appropriate to recovery-focused goals based on individuals' clinical status.
SYSTEMATIC REVIEW REGISTRATION
PROSPERO CRD42016037868.
Identifiants
pubmed: 31128591
doi: 10.1186/s13643-019-1042-4
pii: 10.1186/s13643-019-1042-4
pmc: PMC6535183
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
125Références
Bipolar Disord. 2018 Mar;20(2):97-170
pubmed: 29536616
Bipolar Disord. 2011 Feb;13(1):87-98
pubmed: 21320256
Ann Med. 2001 Jul;33(5):337-43
pubmed: 11491192
J Affect Disord. 2016 Oct;203:152-157
pubmed: 27289316
Arch Gen Psychiatry. 2002 Oct;59(10):921-8
pubmed: 12365879
Bipolar Disord. 2014 Aug;16(5):471-7
pubmed: 23782499
Psychol Med. 1999 Jul;29(4):869-78
pubmed: 10473314
Int J Geriatr Psychiatry. 2000 Jun;15(6):548-61
pubmed: 10861923
Bipolar Disord. 2004 Aug;6(4):305-13
pubmed: 15225148
Psychol Med. 2014 Dec;44(16):3455-67
pubmed: 25066366
Bipolar Disord. 2018 May 8;:
pubmed: 29737625
Acta Psychiatr Scand. 2014 Jun;129(6):437-44
pubmed: 24628576
Arch Gen Psychiatry. 1987 Jun;44(6):540-8
pubmed: 3579500
Bipolar Disord. 2011 Aug-Sep;13(5-6):571-7
pubmed: 22017225
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Acta Neuropsychiatr. 2010 Apr;22(2):50-3
pubmed: 25385029
Mol Psychiatry. 2015 Feb;20(1):23-31
pubmed: 25048003
Neurology. 1999 Jan 15;52(2):231-8
pubmed: 9932936
Bipolar Disord. 2020 May;22(3):231-244
pubmed: 31730294
Clin Psychol Rev. 2017 Mar;52:148-163
pubmed: 28129636
Clin Pract Epidemiol Ment Health. 2007 Jun 07;3:5
pubmed: 17555558
Arch Clin Neuropsychol. 2006 Aug;21(5):413-20
pubmed: 16843636
J Affect Disord. 2014 Mar;156:46-55
pubmed: 24439829
Can J Psychiatry. 2010 Aug;55(8):486-97
pubmed: 20723276
Bipolar Disord. 2010 Nov;12(7):727-40
pubmed: 21040290
Med Care. 1994 Jan;32(1):40-66
pubmed: 8277801
Lancet. 2013 May 11;381(9878):1672-82
pubmed: 23663953
Acta Psychiatr Scand. 2016 Aug;134(2):91-103
pubmed: 27097559
ANS Adv Nurs Sci. 1985 Oct;8(1):15-24
pubmed: 3933411
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
Br J Psychiatry. 2014 Feb;204(2):122-8
pubmed: 24262817
J Psychiatry Neurosci. 2009 Jul;34(4):263-71
pubmed: 19568477
Braz J Psychiatry. 2015 Apr-Jun;37(2):121-5
pubmed: 26018648
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
J Affect Disord. 2015 Jun 1;178:46-51
pubmed: 25795535
Aust N Z J Psychiatry. 2015 Dec;49(12):1085-6
pubmed: 26494849
J Affect Disord. 2016 Sep 01;201:203-14
pubmed: 27243619
Arch Gen Psychiatry. 2003 Apr;60(4):402-7
pubmed: 12695318
Bipolar Disord. 2008 Jun;10(4):511-9
pubmed: 18452447
J Int Neuropsychol Soc. 2004 Mar;10(2):301-3
pubmed: 15012851
Int J Geriatr Psychiatry. 2000 Nov;15(11):1021-7
pubmed: 11113982
Br J Psychiatry. 1990 Dec;157:853-9
pubmed: 2289094
Psychiatry Res. 2002 Oct 10;112(2):161-82
pubmed: 12429362
Acta Psychiatr Scand. 2015 Jun;131(6):458-64
pubmed: 25640667
J Affect Disord. 2010 Jun;123(1-3):81-6
pubmed: 19853922
Aust N Z J Psychiatry. 2012 Feb;46(2):92-9
pubmed: 22311525
Schizophr Bull. 2001;27(2):235-45
pubmed: 11354591
Neurotox Res. 2011 Feb;19(2):279-85
pubmed: 20461491
J Psychopharmacol. 2016 Jun;30(6):495-553
pubmed: 26979387
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Lancet Psychiatry. 2015 Jun;2(6):564-70
pubmed: 26360452
Int J Soc Psychiatry. 1999 Spring;45(1):7-12
pubmed: 10443245
Soc Sci Med. 1995 Nov;41(10):1403-9
pubmed: 8560308
J Affect Disord. 2007 Jun;100(1-3):279-81
pubmed: 17433450
J Nerv Ment Dis. 1997 Mar;185(3):166-75
pubmed: 9091598
J Psychiatr Res. 2012 May;46(5):561-73
pubmed: 22444599
Acta Psychiatr Scand. 2013 Feb;127(2):153-8
pubmed: 22943487
Ann Gen Psychiatry. 2015 Jul 07;14:19
pubmed: 26155299
Br J Psychiatry. 2016 Mar;208(3):213-22
pubmed: 26932483
Br J Psychiatry. 2006 Apr;188:313-20
pubmed: 16582056
Soc Sci Med. 1998 Jun;46(12):1569-85
pubmed: 9672396
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Health Policy. 1992 Oct;22(3):307-19
pubmed: 10122730
Int J Bipolar Disord. 2016 Dec;4(1):19
pubmed: 27613276
Int J Neuropsychopharmacol. 2009 May;12(4):447-58
pubmed: 18771602
Soc Psychiatry Psychiatr Epidemiol. 2001 Jan;36(1):36-44
pubmed: 11320806
Am J Psychiatry. 2013 Aug;170(8):852-9
pubmed: 23511717
J Am Geriatr Soc. 2002 Mar;50(3):530-4
pubmed: 11943052
Psychopharmacol Bull. 1993;29(2):321-6
pubmed: 8290681
J Clin Epidemiol. 2009 Oct;62(10):e1-34
pubmed: 19631507
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
J Affect Disord. 2013 Jan 10;144(1-2):65-71
pubmed: 22862890
Br J Psychiatry. 2013 Apr;202(4):243-5
pubmed: 23549937
Bipolar Disord. 2009 Aug;11(5):474-82
pubmed: 19624386
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
J Clin Psychiatry. 2015 Mar;76(3):e342-50
pubmed: 25830456
Braz J Psychiatry. 2017 Apr-Jun;39(2):88-89
pubmed: 28591270
Schizophr Res. 2011 Mar;126(1-3):124-31
pubmed: 21159492
Turk Psikiyatri Derg. 2007 Winter;18(4):344-52
pubmed: 18066725
Acta Psychiatr Scand. 2014 Nov;130(5):354-63
pubmed: 24961757
Br J Psychiatry. 1995 May;166(5):654-9
pubmed: 7620753
Bipolar Disord. 2007 Nov;9(7):671-8
pubmed: 17988356
Arch Clin Neuropsychol. 1996;11(4):329-38
pubmed: 14588937
Psychiatry Res. 2009 Jan 30;165(1-2):163-74
pubmed: 19042030
J Clin Psychiatry. 2014 May;75(5):e450-6
pubmed: 24922497
Compr Psychiatry. 2013 Aug;54(6):618-26
pubmed: 23357126
Expert Rev Neurother. 2009 Jul;9(7):957-66
pubmed: 19589046
J Int Neuropsychol Soc. 2008 Sep;14(5):869-77
pubmed: 18764982
J Psychiatry Neurosci. 2016 Aug;41(5):291-3
pubmed: 27575857
J Clin Psychol. 1972 Apr;28(2):167-9
pubmed: 5019979
Syst Rev. 2017 Mar 23;6(1):61
pubmed: 28335799